- Home
- AGYS vs VKTX Comparison
AGYS vs VKTX Comparison
Compare AGYS & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGYS
- VKTX
- Stock Information
- Founded
- AGYS 1963
- VKTX 2012
- Country
- AGYS United States
- VKTX United States
- Employees
- AGYS N/A
- VKTX N/A
- Industry
- AGYS EDP Services
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- AGYS Technology
- VKTX Health Care
- Exchange
- AGYS Nasdaq
- VKTX Nasdaq
- Market Cap
- AGYS 3.2B
- VKTX 3.5B
- IPO Year
- AGYS N/A
- VKTX 2015
- Fundamental
- Price
- AGYS $114.99
- VKTX $34.03
- Analyst Decision
- AGYS Strong Buy
- VKTX Strong Buy
- Analyst Count
- AGYS 5
- VKTX 13
- Target Price
- AGYS $131.20
- VKTX $86.92
- AVG Volume (30 Days)
- AGYS 265.7K
- VKTX 3.8M
- Earning Date
- AGYS 07-21-2025
- VKTX 07-23-2025
- Dividend Yield
- AGYS N/A
- VKTX N/A
- EPS Growth
- AGYS N/A
- VKTX N/A
- EPS
- AGYS 0.49
- VKTX N/A
- Revenue
- AGYS $288,787,000.00
- VKTX N/A
- Revenue This Year
- AGYS $14.98
- VKTX N/A
- Revenue Next Year
- AGYS $17.36
- VKTX $338.60
- P/E Ratio
- AGYS $234.65
- VKTX N/A
- Revenue Growth
- AGYS 17.91
- VKTX N/A
- 52 Week Low
- AGYS $63.71
- VKTX $18.92
- 52 Week High
- AGYS $142.64
- VKTX $81.73
- Technical
- Relative Strength Index (RSI)
- AGYS 51.16
- VKTX 63.93
- Support Level
- AGYS $111.45
- VKTX $31.80
- Resistance Level
- AGYS $118.82
- VKTX $34.60
- Average True Range (ATR)
- AGYS 4.57
- VKTX 1.77
- MACD
- AGYS -0.36
- VKTX -0.04
- Stochastic Oscillator
- AGYS 75.10
- VKTX 67.25
About AGYS Agilysys Inc.
Agilysys Inc provides hospitality software delivering cloud-native SaaS and on-premise solutions for hotels, resorts, cruise lines, casinos, corporate foodservice management, restaurants, universities, stadiums, and healthcare facilities. The company's software solutions include point-of-sale (POS), property management (PMS), inventory and procurement, payments, and related applications that manage and enhance the entire guest journey. It derives maximum revenue from the provision of software subscription and maintenance services, followed by the provision of professional services, and the sale of products (proprietary software licenses, third-party hardware, and operating systems). Agilysys operates across North America, Europe, the Middle East, Asia-Pacific, and India.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.